Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study
European Thyroid Journal · 2026
DOI: 10.1530/etj-25-0292 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Thyroid Journal, 2026. Verfasst von Samuel Frey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Nantes, France. Hauptthemen laut MEDLINE: Thyrotoxicosis, Amiodarone, Thyroidectomy, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Amiodarone-induced thyrotoxicosis (AIT) affects 5–10% of patients on amiodarone therapy, increasing cardiovascular (CV) risk. Total thyroidectomy is proposed for refractory cases, but its long-term impact on major adverse cardiovascular events (MACEs) remains uncertain. This study evaluates post-operative MACEs and cardiac mortality in AIT patients with and without pre-operative left ventricular ejection fraction (LVEF) impairment.
Methods
Patients undergoing total thyroidectomy for AIT from 2010 to 2023 in two French referral centers were retrospectively included. They were divided into two groups based on pre-operative LVEF (<40% vs ≥40%). The main outcomes were the post-operative MACEs and cardiac mortality at one and five years.
Results
Among 101 patients, 26 had LVEF < 40% (group 1), while 75 had LVEF ≥ 40% (group 2). Patients in group 1 were younger, had higher ASA (American Society of Anesthesia) scores, and had more severe cardiac conditions. The median duration of exposure to AIT was 2.7 (Q1; Q3 1.3; 4.7) months. Overall, perioperative mortality was 2.0%. Group 1 showed higher 5-year MACE occurrence (61.4 vs 24.0%, P = 0.0005) and higher cardiac mortality (30.8 vs 1.3%, P = 0.0001). Multivariate regression identified younger age at AIT diagnosis and baseline LVEF < 40% as significantly associated with a higher 5-year MACE rate. Among patients with baseline LVEF < 40%, those with early post-operative LVEF improvement displayed a lower rate of 5-year MACEs (47.1 vs 100%, P = 0.022).
Conclusion
Patients with LVEF < 40% carries a high long-term CV risk despite early thyroidectomy. Post-operative LVEF assessment may help identify high-risk patients. In contrast, those with LVEF ≥ 40% have a favorable prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nantes Université, CHU Nantes, Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Nantes, France.
- Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
- Nantes Université, CHU Nantes, DRCI, Département Promotion, Nantes, France.
- Service d'endocrinologie, Hôpital Louis-Pradel, Hospices civils de Lyon, Lyon, France.
- Nantes Université, CHU Nantes, Service d'Endocrinologie, Diabétologie et Nutrition, l'institut du thorax, Nantes, France.
- Nantes Université, CHU Nantes, Service de cardiologie, Hôpital Nord Laennec, Nantes, France.
ORCID-Profile: Samuel Frey
Zitieren
APA
Frey, S., Volteau, C., Lasolle, H., Caillard, C., Drui, D., Pattier, S., Borson-Chazot, F., Maillard, L., Lifante, J. C., & Mirallié, E. (2026). Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study. European Thyroid Journal. https://doi.org/10.1530/etj-25-0292
Vancouver
Frey S, Volteau C, Lasolle H, Caillard C, Drui D, Pattier S, et al. Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study. European Thyroid Journal. 2026. doi:10.1530/etj-25-0292
BibTeX
@article{Frey2026,
author = {Frey, Samuel and Volteau, Christelle and Lasolle, Hélène and Caillard, Cécile and Drui, Delphine and Pattier, Sabine and Borson-Chazot, Françoise and Maillard, Laure and Lifante, Jean-Christophe and Mirallié, Eric},
title = {Major adverse cardiac events in patients with amiodarone-induced thyrotoxicosis undergoing thyroidectomy: a multicenter study},
journal = {European Thyroid Journal},
year = {2026},
doi = {10.1530/etj-25-0292}
}
EUVIMED